Plain-English translation of NCT06520098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether adding —a second medication—to a blood cancer pill you may already be taking can help control chronic lymphocytic leukemia or small lymphocytic lymphoma better. Some recent studies suggest that combining these two medications for about a year might allow people to stop treatment entirely, which would be a major breakthrough since most patients normally take their current medication for life. This study wants to find out if this combination works as well in veterans and whether it truly allows people to safely stop their medication.
Right now, people with this type of blood cancer usually take their medication forever because stopping it causes the cancer to come back. Recent research suggests that the medication combination might work so well that patients could stop treatment after a year or two—but doctors need to confirm this works and is safe for the veterans in the VA system.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups: continue taking your current single medication, or add the second medication () to your current pill for 12 months and then stop both. You will have regular clinic visits and blood tests to check how the cancer is responding and how you are tolerating the treatment. The study team will track your symptoms, side effects, and quality of life throughout the trial to compare how each approach affects you.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States